InvestSMART

Rhythm Biosciences Limited (ASX: RHY) - Announcements

Current share price for RHY : $0.097 0.005 (5.43%)+

ASX company news and announcements for Rhythm Biosciences Limited (RHY) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Rhythm Biosciences Limited (RHY) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Rhythm Biosciences Limited (RHY), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Rhythm Biosciences Limited (RHY)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$34 Bioshares 2026 Presentation 6 Aug 2026 8:38AM $0.086 $0.097 risen by 12.79%
$34 Quarterly Activities Report and Appendix 4C 30 Jul 2026 8:33AM $0.081 $0.097 risen by 19.75%
$34 New Lung Cancer Genetype Risk Assessment Test 21 Jul 2026 8:30AM $0.086 $0.097 risen by 12.79%
$34 Accreditation Matters Conference Presentation 7 Jul 2026 8:26AM $0.093 $0.097 risen by 4.30%
$34 Rhythm launches tailored ColoSTAT marketing campaign 2 Jul 2026 8:24AM $0.100 $0.097 fallen by 3%
$34 Rhythm Bio Singapore Investor Presentation 4 Jun 2026 8:24AM $0.115 $0.097 fallen by 15.65%
$34 ColoSTAT Access Program Gains Momentum 26 May 2026 8:49AM $0.130 $0.097 fallen by 25.38%
$34 Investor Presentation 13 May 2026 10:08AM $0.135 $0.097 fallen by 28.15%
$34 ColoSTAT Demonstrates Early Clinical Adoption 6 May 2026 8:28AM $0.135 $0.097 fallen by 28.15%
$34 Investor Webinar 5 May 2026 11:04AM $0.130 $0.097 fallen by 25.38%
$34 Quarterly Activities Report and Appendix 4C 30 Apr 2026 9:31AM $0.140 $0.097 fallen by 30.71%
$34 RHYO Underwriting Update 28 Apr 2026 5:24PM $0.150 $0.097 fallen by 35.33%
$34 Application for quotation of securities - RHY 17 Apr 2026 4:28PM $0.190 $0.097 fallen by 48.95%
$34 Cleansing Notice 15 Apr 2026 5:04PM $0.195 $0.097 fallen by 50.26%
$34 Application for quotation of securities - RHY 15 Apr 2026 4:45PM $0.195 $0.097 fallen by 50.26%
$34 Response to ASX Query Letter 14 Apr 2026 4:53PM $0.195 $0.097 fallen by 50.26%
$34 Completion Of RHYO Option Underwriting 14 Apr 2026 3:32PM $0.195 $0.097 fallen by 50.26%
$34 Change of Director's Interest Notice 7 Apr 2026 4:39PM $0.180 $0.097 fallen by 46.11%
$34 Notification of cessation of securities - RHY 7 Apr 2026 4:35PM $0.180 $0.097 fallen by 46.11%
$34 Proposed issue of securities - RHY 2 Apr 2026 5:43PM $0.190 $0.097 fallen by 48.95%
$34 Application for quotation of securities - RHY 2 Apr 2026 5:41PM $0.190 $0.097 fallen by 48.95%
$34 RHYO Options Underwriting Agreement 31 Mar 2026 9:25AM $0.195 $0.097 fallen by 50.26%
$34 Prospectus 30 Mar 2026 8:40AM $0.185 $0.097 fallen by 47.57%
$34 Rapid Expansion of ColoSTAT Commercial Roll Out 30 Mar 2026 8:23AM $0.185 $0.097 fallen by 47.57%
$34 Application for quotation of securities - RHY 27 Mar 2026 4:31PM $0.185 $0.097 fallen by 47.57%

1 - 25 of 639 results

Page 1 of 26

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.